StonvexLoading…
StonvexStonvexStonvexCore line items from TWST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $376.57M | $312.97M | $245.11M | $203.56M |
Operating Income | $-136.26M | $-220.83M | $-217.16M | $-234.78M |
Net Income | $-77.67M | $-208.73M | $-204.62M | $-217.86M |
EPS (Diluted) | $-1.30 | $-3.60 | $-3.60 | $-4.04 |
Total Assets | $641.86M | $614.32M | $776.40M | $961.38M |
Total Liabilities | $168.90M | $141.63M | $152.97M | $171.99M |
Cash & Equivalents | $183.05M | $226.32M | $286.47M | $378.69M |
Free Cash Flow OCF − CapEx | $-75.63M | $-69.17M | $-170.25M | $-226.24M |
Shares Outstanding | 60.63M | 58.88M | 57.56M | 56.52M |